Skip to content

The Pfizer Documents - July 2022 Update

Sign up to create lists
Report The Pfizer Documents - July 2022 Update
Unverified source. This magnet is from an unverified source. The content may be unsafe or mislabeled. Proceed with caution.
Title: The Pfizer Documents - JulyGroup: NOGRPYear: 2022
Info Hash
098BDF41DDB0E77FC3E6A05DAE59DC709F272ABE
Source
Unverified
Total Size
11.31 GB
Total Files
100
Seeders
0
Leechers
1
Health
Score
1
Type
eBook

File List

FileSize
pd-production-011822/CRFs-for-site-1096.pdf11.28 MB
.pad/758343740.57 KB
pd-production-013122/CRFs-for-site-1128.pdf13.55 MB
.pad/470569459.54 KB
pd-production-030122/125742_S1_M1_356h.pdf714.46 KB
.pad/13655451.3 MB
pd-production-030122/125742_S1_M1_3674.pdf5.12 MB
.pad/925235903.55 KB
pd-production-030122/125742_S1_M1_cover.pdf1.32 MB
.pad/717662700.84 KB
pd-production-030122/125742_S1_M1_debarment.pdf656.42 KB
.pad/14249821.36 MB
pd-production-030122/125742_S1_M1_exclusivity-claim.pdf616.11 KB
.pad/14662591.4 MB
pd-production-030122/125742_S1_M1_fast-track-designation.pdf649.42 KB
.pad/14321491.37 MB
pd-production-030122/125742_S1_M1_financial-cert-3454.pdf3.44 MB
.pad/590670576.83 KB
pd-production-030122/125742_S1_M1_financial-cert-bias.pdf695.81 KB
.pad/13846421.32 MB
pd-production-030122/125742_S1_M1_ipsp-agreed-letter.pdf657.84 KB
.pad/14235241.36 MB
pd-production-030122/125742_S1_M1_priority-review-request.pdf1.59 MB
.pad/432507422.37 KB
pd-production-030122/125742_S1_M1_trans-of-oblig.pdf717.14 KB
.pad/13628041.3 MB
pd-production-030122/125742_S1_M1_us-agent-authorization.pdf1.03 MB
.pad/1012417988.69 KB
pd-production-030122/125742_S1_M1_userfee.pdf627.8 KB
.pad/14542851.39 MB
pd-production-030122/125742_S1_M1_waiver-req-designated-suffix.pdf2.74 MB
.pad/13257611.26 MB
pd-production-030122/125742_S1_M2_22_introduction.pdf670.17 KB
.pad/14109001.35 MB
pd-production-030122/125742_S1_M2_24_nonclinical-overview.pdf1.61 MB
.pad/408351398.78 KB
pd-production-030122/125742_S1_M2_26_pharmkin-tabulated-summary.pdf1.34 MB
.pad/688988672.84 KB
pd-production-030122/125742_S1_M2_26_pharmkin-written-summary.pdf1.43 MB
.pad/600163586.1 KB
pd-production-030122/125742_S1_M2_27_literature-references.pdf1.75 MB
.pad/264301258.11 KB
pd-production-030122/125742_S1_M2_27_synopses-indiv-studies.pdf1.75 MB
.pad/263583257.41 KB
pd-production-030122/125742_S1_M4_4223_185350.pdf1.4 MB
.pad/629773615.01 KB
pd-production-030122/125742_S1_M4_4223_R-20-0072.pdf5.21 MB
.pad/823457804.16 KB
pd-production-030122/125742_S1_M5_5351_c4591001-ad-hoc-label-tables.pdf889.15 KB
.pad/11866621.13 MB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-compliance-sensitive.pdf1.26 MB
.pad/778153759.92 KB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-compliance.pdf2.04 MB
.pad/20550351.96 MB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-efficacy-response.pdf2.39 MB
.pad/16912251.61 MB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-errata.pdf2.27 MB
.pad/18188481.73 MB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-excluded-patients-sensitive.pdf15.7 MB
.pad/312541305.22 KB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-excluded-patients.pdf1.81 MB
.pad/196859192.25 KB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-lab-measurements-sensitive.pdf4.78 MB
.pad/12760061.22 MB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-lab-measurements.pdf12.02 MB
.pad/20751061.98 MB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-oversight-committees.pdf2.29 MB
.pad/17944261.71 MB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-protocol.pdf31.31 MB
.pad/727002709.96 KB
pd-production-030122/125742_S1_M5_5351_c4591001-interim-mth6-oversight-committees.pdf13 MB
.pad/10511781 MB
pd-production-030122/125742_S1_M5_5351_c4591001-interim-mth6-protocol.pdf36.94 MB
.pad/11143701.06 MB
pd-production-030122/125742_S1_M5_CRF_c4591001-1085-10851018.pdf2.25 MB
.pad/18323521.75 MB
pd-production-030122/125742_S1_M5_CRF_c4591001-1085-10851116.pdf1.19 MB
.pad/845807825.98 KB
pd-production-030122/125742_S1_M5_CRF_c4591001-1085-10851129.pdf1.94 MB
.pad/6625464.7 KB
pd-production-030122/125742_S1_M5_CRF_c4591001-1085-10851216.pdf1.22 MB
.pad/814548795.46 KB
pd-production-030122/125742_S1_M5_CRF_c4591001-1085-10851246.pdf1.14 MB
.pad/898888877.82 KB
pd-production-030122/125742_S1_M5_c4591001-A-201114-hiv-preferred-terms.pdf602.23 KB
.pad/14804711.41 MB
pd-production-030122/125742_S1_M5_c4591001-A-adrg.pdf1.54 MB
.pad/484750473.39 KB
pd-production-030122/125742_S1_M5_c4591001-A-bmi-12-15-scale.pdf627.05 KB
.pad/14550551.39 MB
pd-production-030122/125742_S1_M5_c4591001-A-c4591001-phase-1-subjects-from-dmw.pdf634.25 KB
.pad/14476771.38 MB
pd-production-030122/125742_S1_M5_c4591001-A-c4591001-subject-list-for-12-25-immuno-analysis-27jan2021.pdf620.2 KB
.pad/14620661.39 MB
pd-production-030122/125742_S1_M5_c4591001-A-comorbidity-categories.pdf636.9 KB
.pad/14449711.38 MB
pd-production-030122/125742_S1_M5_c4591001-A-first-c4591001-360-participants-enrolled-v1-13aug20-update.pdf606.89 KB
.pad/14756981.41 MB
pd-production-030122/125742_S1_M5_c4591001-A-newlist-c4591001-6k-participants-enrolled-v3-17sep2020.pdf846.03 KB
.pad/12308151.17 MB

Trackers

No trackers found.